These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

240 related items for PubMed ID: 27035631

  • 1. Autophagy inhibition facilitates erlotinib cytotoxicity in lung cancer cells through modulation of endoplasmic reticulum stress.
    Wang Z, Du T, Dong X, Li Z, Wu G, Zhang R.
    Int J Oncol; 2016 Jun; 48(6):2558-66. PubMed ID: 27035631
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Erlotinib-induced autophagy in epidermal growth factor receptor mutated non-small cell lung cancer.
    Li YY, Lam SK, Mak JC, Zheng CY, Ho JC.
    Lung Cancer; 2013 Sep; 81(3):354-361. PubMed ID: 23769318
    [Abstract] [Full Text] [Related]

  • 4. Focal Adhesion Kinase Inhibitors in Combination with Erlotinib Demonstrate Enhanced Anti-Tumor Activity in Non-Small Cell Lung Cancer.
    Howe GA, Xiao B, Zhao H, Al-Zahrani KN, Hasim MS, Villeneuve J, Sekhon HS, Goss GD, Sabourin LA, Dimitroulakos J, Addison CL.
    PLoS One; 2016 Sep; 11(3):e0150567. PubMed ID: 26962872
    [Abstract] [Full Text] [Related]

  • 5. Chloroquine in combination with aptamer-modified nanocomplexes for tumor vessel normalization and efficient erlotinib/Survivin shRNA co-delivery to overcome drug resistance in EGFR-mutated non-small cell lung cancer.
    Lv T, Li Z, Xu L, Zhang Y, Chen H, Gao Y.
    Acta Biomater; 2018 Aug; 76():257-274. PubMed ID: 29960010
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. The repression and reciprocal interaction of DNA methyltransferase 1 and specificity protein 1 contributes to the inhibition of MET expression by the combination of Chinese herbal medicine FZKA decoction and erlotinib.
    Zheng F, Zhao Y, Li X, Tang Q, Wu J, Wu W, Hann SS.
    J Ethnopharmacol; 2019 Jul 15; 239():111928. PubMed ID: 31077779
    [Abstract] [Full Text] [Related]

  • 8. Combination treatment with erlotinib and ampelopsin overcomes erlotinib resistance in NSCLC cells via the Nox2-ROS-Bim pathway.
    Hong SW, Park NS, Noh MH, Shim JA, Ahn BN, Kim YS, Kim D, Lee HK, Hur DY.
    Lung Cancer; 2017 Apr 15; 106():115-124. PubMed ID: 28285685
    [Abstract] [Full Text] [Related]

  • 9. The autophagy inhibitor chloroquine overcomes the innate resistance of wild-type EGFR non-small-cell lung cancer cells to erlotinib.
    Zou Y, Ling YH, Sironi J, Schwartz EL, Perez-Soler R, Piperdi B.
    J Thorac Oncol; 2013 Jun 15; 8(6):693-702. PubMed ID: 23575415
    [Abstract] [Full Text] [Related]

  • 10. Tyr1068-phosphorylated epidermal growth factor receptor (EGFR) predicts cancer stem cell targeting by erlotinib in preclinical models of wild-type EGFR lung cancer.
    Sette G, Salvati V, Mottolese M, Visca P, Gallo E, Fecchi K, Pilozzi E, Duranti E, Policicchio E, Tartaglia M, Milella M, De Maria R, Eramo A.
    Cell Death Dis; 2015 Aug 06; 6(8):e1850. PubMed ID: 26247735
    [Abstract] [Full Text] [Related]

  • 11. Nicotine induces resistance to erlotinib via cross-talk between α 1 nAChR and EGFR in the non-small cell lung cancer xenograft model.
    Li H, Wang S, Takayama K, Harada T, Okamoto I, Iwama E, Fujii A, Ota K, Hidaka N, Kawano Y, Nakanishi Y.
    Lung Cancer; 2015 Apr 06; 88(1):1-8. PubMed ID: 25670150
    [Abstract] [Full Text] [Related]

  • 12. 2-Deoxy-d-glucose Suppresses the In Vivo Antitumor Efficacy of Erlotinib in Head and Neck Squamous Cell Carcinoma Cells.
    Sobhakumari A, Orcutt KP, Love-Homan L, Kowalski CE, Parsons AD, Knudson CM, Simons AL.
    Oncol Res; 2016 Apr 06; 24(1):55-64. PubMed ID: 27178822
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Combined treatment with erlotinib and a transforming growth factor-β type I receptor inhibitor effectively suppresses the enhanced motility of erlotinib-resistant non-small-cell lung cancer cells.
    Serizawa M, Takahashi T, Yamamoto N, Koh Y.
    J Thorac Oncol; 2013 Mar 06; 8(3):259-69. PubMed ID: 23334091
    [Abstract] [Full Text] [Related]

  • 16. Inhibition of JAK1/2 can overcome EGFR-TKI resistance in human NSCLC.
    Kim DM, Kim MJ, Moon JH, Lee EY, Hong JK, Lee S, Koh DI, Ryu YS, Kim SM, Jung SA, Shin JS, Kim J, Park YS, Hong SW, Lee SH, Jung J, Park SS, Kim DY, Kim EH, Jeong HR, Gong JH, Kim J, Chan Kim S, Yu HN, Ki SY, Kim TW, Jin DH.
    Biochem Biophys Res Commun; 2020 Jun 18; 527(1):305-310. PubMed ID: 32446385
    [Abstract] [Full Text] [Related]

  • 17. GATA6-upregulating autophagy promotes TKI resistance in nonsmall cell lung cancer.
    Ma R, Li X, Liu H, Jiang R, Yang M, Zhang M, Wang Y, Zhao Y, Li H.
    Cancer Biol Ther; 2019 Jun 18; 20(9):1206-1212. PubMed ID: 31092103
    [Abstract] [Full Text] [Related]

  • 18. Antitumor activity of combination treatment with gefitinib and docetaxel in EGFR-TKI-sensitive, primary resistant and acquired resistant human non-small cell lung cancer cells.
    Wu M, Yuan Y, Pan YY, Zhang Y.
    Mol Med Rep; 2014 Jun 18; 9(6):2417-22. PubMed ID: 24682085
    [Abstract] [Full Text] [Related]

  • 19. MET Gene Amplification and MET Receptor Activation Are Not Sufficient to Predict Efficacy of Combined MET and EGFR Inhibitors in EGFR TKI-Resistant NSCLC Cells.
    Presutti D, Santini S, Cardinali B, Papoff G, Lalli C, Samperna S, Fustaino V, Giannini G, Ruberti G.
    PLoS One; 2015 Jun 18; 10(11):e0143333. PubMed ID: 26580964
    [Abstract] [Full Text] [Related]

  • 20. The combination of multiple receptor tyrosine kinase inhibitor and mammalian target of rapamycin inhibitor overcomes erlotinib resistance in lung cancer cell lines through c-Met inhibition.
    Nakachi I, Naoki K, Soejima K, Kawada I, Watanabe H, Yasuda H, Nakayama S, Yoda S, Satomi R, Ikemura S, Terai H, Sato T, Ishizaka A.
    Mol Cancer Res; 2010 Aug 18; 8(8):1142-51. PubMed ID: 20647329
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.